HYPERTENSION MANAGEMENT IN THE EMERGENCY ROOM
Main Article Content
Keywords
High blood pressure, Pathophysiology, Treatment.
Abstract
Background: Hypertension, also recognized as elevated blood pressure, is a persistent medical condition defined by blood pressure measurements that surpass 120/80 mmHg, and tend to increase with age, linked with heightened cardiovascular dangers. This situation plays a notable role in the progression of heart disease, stroke, and renal issues, requiring a blend of medicinal treatments and adjustments in lifestyle. On a global scale, hypertension impacts a staggering 1.13 billion individuals, disproportionately affecting populations in low- and middle-income countries where awareness and control rates are notably deficient. The diagnosis of hypertension demands multiple blood pressure assessments and may entail sophisticated methodologies such as photoplethysmography. Symptoms of this condition include headaches, dizziness, and fatigue, while routine laboratory evaluations are imperative for detecting associated medical conditions. Sustained management strategies are paramount in mitigating the onset of severe complications.
Aim: to understand hypertension, covering its epidemiology, symptoms, pathophysiology, diagnosis, control and prevention, and treatment options to improve treatment outcomes.
Method: a comprehensive review of Hypertension and therapy. The PUBMED and Google Scholar search engines were the main databases used for the search process, with articles collected from 2018 to 2024.
Conclusion: hypertension, a persistent elevation in blood pressure above 120/80 mmHg, significantly impacts cardiovascular health, increasing the risk of severe conditions like coronary artery disease, heart failure, stroke, and renal insufficiency. Effective management through medication and lifestyle changes, such as the DASH diet, regular exercise, and stress management, is crucial. Advanced diagnostic techniques and personalized treatment strategies, including combination therapy, enhance patient outcomes. Continued emphasis on early detection, especially in children, and out-of-office blood pressure monitoring are essential to prevent long-term complications and improve global hypertension control.
References
2. Mills KT, Stefanescu A, He JJNRN. The global epidemiology of hypertension. 2020;16(4):223-37.
3. Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nature Reviews Cardiology. 2021;18(11):785-802.
4. Ralapanawa U. RAG-SACA-2: EPIDEMIOLOGY OF HYPERTENSION IN SOUTH ASIA. 2023;41(Suppl 1):e169.
5. Wolley M, Stowasser M. 31C4Diagnosis and investigation of hypertension. In: Nadar SK, Lip GYH, Nadar S, Lip G, editors. Hypertension (Oxford Cardiology Library) 3E: Oxford University Press; 2022. p. 0.
6. Aydemir T, Sahin M, Aydemir OJBP, Express E. Determination of hypertension disease using chirp z-transform and statistical features of optimal band-pass filtered short-time photoplethysmography signals. 2020;6(6):065033.
7. Kim JS, Rhee M-Y, Kim CH, Kim YR, Do U, Kim J-H, et al. Algorithm for diagnosing hypertension using out-of-office blood pressure measurements. 2021;23(11):1965-74.
8. Middeke M, Lemmer B, Schaaf B, Eckes L. Prevalence of hypertension-attributed symptoms in routine clinical practice: a general practitioners-based study. Journal of Human Hypertension. 2008;22(4):252-8.
9. Zehra SN, Anwar A, Kamran S, Jawaid H, Maheen S, Ariff M. Effect of hypertension duration on relationship between blood pressure and signs and symptoms in hypertensive patients:a cross sectional survey. International Journal of Research in Medical Sciences. 2019;7(7):2588-94.
10. Achmad S, quot, id, Hella Meldy T, Budiman MEA. THE EKSPLORASI KEBUTUHAN PASIEN HIPERTENSI PADA WILAYAH URBAN KABUPATEN JEMBER. PROFESSIONAL HEALTH JOURNAL. 2023;4(2).
11. CHEN N, CHENG G, WEI B, BI Q, LU C, WANG S, et al. Microglia contribute to the autonomic function and participate in neurogenic hypertension: non-immune function of central immune cells. 2022;52(12):1773-84.
12. Aralica M, Šupak-Smolčić V, Honović L, Franin L, Šonjić P, Šimac M, et al. Laboratory medicine in arterial hypertension. 2023;33(1):10-20.
13. Quan S, Chen G, Padwal RS, McAlister FA, Tran KC, Campbell NRC, et al. Frequency of laboratory testing and associated abnormalities in patients with hypertension. 2020;22(11):2077-83.
14. Rossi GP, Seccia TM, Pessina AC. Clinical Use of Laboratory Tests for the Identification of Secondary Forms of Arterial Hypertension. Critical Reviews in Clinical Laboratory Sciences. 2007;44(1):1-85.
15. Ghosh R, Bhattacharyya M, Khan G, Chakraborty S, Bhattacharya R, Maji UK, et al. Diagnosis of essential hypertension in humans by the determination of plasma renal cortexin using enzyme-linked immunosorbent assay. 2013;59(475):81.
16. Sharma A, Choi JSY, Watson AMD, Li L, Sonntag T, Lee MKS, et al. Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities. Scientific reports. 2023;13(1):8741.
17. Manolis AJ, Kallistratos MS, Vlahakos DV, Mitrakou A, Poulimenos LE. Comorbidities Often Associated with Brain Damage in Hypertension: Diabetes, Coronary Artery Disease, Chronic Kidney Disease and Obstructive Sleep Apnoea. In: Coca A, editor. Hypertension and Brain Damage. Cham: Springer International Publishing; 2016. p. 35-46.
18. Osmanov EM, Reshetnikov VA, Manyakov RR, Garaeva AS, Korkmazova LK, Demenkova VV. Comorbid status of patients with hypertension. TA. 2023;95(1):11-6 %J TA.
19. Goyat R. The Impact of Comorbidities on Diabetes and Hypertension Co-Management and Healthcare Expenditures: West Virginia University; 2018.
20. Mary S, Rossitto G, Delles C. 11C2Pathophysiology of hypertension. In: Nadar SK, Lip GYH, Nadar S, Lip G, editors. Hypertension (Oxford Cardiology Library) 3E: Oxford University Press; 2022. p. 0.
21. Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of Hypertension. 2021;128(7):847-63.
22. Cuspidi C, Tadic M, Sala C, Grassi G. Pathophysiology of hypertensive heart disease. Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment: Springer; 2024. p. 229-41.
23. Singh G, Wander GS. 21C3Secondary hypertension. In: Nadar SK, Lip GYH, Nadar S, Lip G, editors. Hypertension (Oxford Cardiology Library) 3E: Oxford University Press; 2022. p. 0.
24. Daly PL, Goodwin ET, Kipnis CM, Smith DKJFe. Hypertensive Conditions: Secondary Causes of Hypertension in Adults. 2022;522:13-7.
25. Cífková R. Lifestyle Modifications. In: Berbari AE, Mancia G, editors. Blood Pressure Disorders in Diabetes Mellitus. Cham: Springer International Publishing; 2023. p. 367-76.
26. Rahimi A, Nkombua LJSAFP. Hypertensive patients’ knowledge and practices on lifestyle modification in Extension 6, Middelburg. 2022;64(1):5528.
27. Vasilevski M, Hamel R, Rampakakis E, Sampalis J. [PP.30.02] IMPACT OF STRESS REDUCTION ON BLOOD PRESSURE CONTROL IN PATIENTS TREATED WITH PERINDOPRIL; SHAKE THE HABIT II. 2016;34:e307.
28. Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. European Heart Journal. 2021;42(40):4111-22.
29. Kreutz R, Abdel-Hady Algharably E. Novel Drugs in the Treatment of Hypertension. In: Tsioufis C, Schmieder RE, Mancia G, editors. Interventional Therapies for Secondary and Essential Hypertension. Cham: Springer International Publishing; 2016. p. 157-78.
30. Arai K, Homma T, Morikawa Y, Ubukata N, Tsuruoka H, Aoki K, et al. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. 2015;761:226-34.
31. Bergler-Klein J. What’s new in the ESC 2018 guidelines for arterial hypertension. Wiener klinische Wochenschrift. 2019;131(7):180-5.
32. Göknar N, Çalışkan SJTAoPTPA. New guidelines for the diagnosis, evaluation, and treatment of pediatric hypertension. 2020;55(1):11.
33. Lay-Flurrie SL, Sheppard JP, Stevens RJ, Mallen C, Heneghan C, Hobbs FR, et al. Impact of changes to national hypertension guidelines on hypertension management and outcomes in the United Kingdom. 2020;75(2):356-64.
34. Aronow WS, Frishman WH. Implications of the New National Guidelines for Hypertension. 2018;26(2):55-61.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Rawan Ghazi Al Hammad
King Abdulaziz Hospital National Guard Hospital - Al Ahsa - Saudi Arabia
Suad Abdullah AL-Nasser
Imam Abdulrahman Bin Faisal Hospital Dammam Ministry of National Guard Health Affairs - Dammam - Saudi Arabia
Khaled Mohammad Saleh Alhejab
General Directorate Of Health Affairs - Al Qassim - Saudi Arabia
Banin Ali Makki Aljassas
Qateif health network - Qateif - Saudi Arabia
Reema salman Yousef al bouzied
Dammam health Network- Dammam- Saudi Arabia
Mona abdulwahab almotawah
Dammam health Network- Dammam- Saudi Arabia
Wadha salman yousef al bouzaid
Maternity And Children Hospital -Dammam- Saudi Arabia
Fatimah salman albuzaid
Maternity And Children Hospital -Dammam- Saudi Arabia
Reema Hassan Al Khalifa
Qateif health network - Qateif - Saudi Arabia
Emtethal Mansour AlZAHER
Qateif health network - Qateif - Saudi Arabia
Fatemah Ahmed Hassan Alaskari
Dammam health Network- Dammam- Saudi Arabia
Mashaer Ali Mansour Alghuryafi
Dammam health Network- Dammam- Saudi Arabia
Ehsan sharaf ahmed alhawashem
Qateif health network - Qateif - Saudi Arabia
Ahmed Abdulla Alsaud
Jubail General Hospital - Jubail- Saudi Arabia